# Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen

> **NCT01850147** · PHASE2 · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 50 (estimated)

## Conditions studied

- Cancer
- Lung Cancer

## Interventions

- **DRUG:** Sunitinib, chemotherapy

## Key facts

- **NCT ID:** NCT01850147
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2014-10
- **Final completion:** 2014-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01850147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01850147, "Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01850147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*